NCT01129687

Brief Summary

The investigators study is to investigate safety and efficacy of performing a planned incomplete removal of large acoustic neuroma tumors to decrease surgical morbidity and yet avoid tumor recurrence by post-operative radiation therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
157

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2005

Longer than P75 for all trials

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2005

Completed
5 years until next milestone

First Submitted

Initial submission to the registry

March 10, 2010

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 25, 2010

Completed
12 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 8, 2022

Completed
Last Updated

May 10, 2022

Status Verified

May 1, 2022

Enrollment Period

17.2 years

First QC Date

March 10, 2010

Last Update Submit

May 8, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Need for stereotactic radiation therapy should tumor remnant grow on annual MRI's

    10 years

Secondary Outcomes (1)

  • Facial nerve function measured on House-Brackmann scale

    10 y

Study Arms (1)

ANSRS group

Patients qualifying for the study.

Procedure: MicrosurgeryProcedure: Stereotactic radiation therapy

Interventions

MicrosurgeryPROCEDURE

Patient would under to total, near-total, or subtotal resection of tumor

ANSRS group

Patient who has sign of growth of tumor remnant would undergo this treatment

ANSRS group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with large acoustic neuromas measuring 2.5cm in longest dimension in the cerebellopontine angle.

You may qualify if:

  • Adult patients with acoustic neuromas the widest diameter of 2.5 cm or larger at the cerebellopontine angle are eligible for this trial.
  • Patients that are deemed good surgical candidates based on age, general health, genetic predispositions, and hearing in contralateral side would be included as the subjects of this trial.
  • Although we would include patients with neurofibromatosis II in this trial, considering their genetic predisposition for recurrence, we would analyze their outcome as a separate group.

You may not qualify if:

  • Patients who have received any form of treatment of their acoustic neuromas prior to enrollment in the study including surgery or radiation therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

George Washington University

Washington D.C., District of Columbia, 20037, United States

Location

Indiana University

Indianapolis, Indiana, 46202, United States

Location

University of Iowa

Iowa City, Iowa, 52242, United States

Location

Louisiana State University

Baton Rouge, Louisiana, 70808, United States

Location

Weill Cornell Medical College

New York, New York, United States

Location

University of Cincinnati

Cincinnati, Ohio, United States

Location

University of Texas Southwestern

Dallas, Texas, 75390, United States

Location

Baylor College of Medicine

Houston, Texas, United States

Location

MeSH Terms

Conditions

Neuroma, Acoustic

Interventions

MicrosurgeryRadiosurgery

Condition Hierarchy (Ancestors)

NeurilemmomaNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeuromaNerve Sheath NeoplasmsNeoplasms, Nerve TissueCranial Nerve NeoplasmsNervous System NeoplasmsNeoplasms by SitePeripheral Nervous System NeoplasmsVestibulocochlear Nerve DiseasesRetrocochlear DiseasesEar DiseasesOtorhinolaryngologic DiseasesOtorhinolaryngologic NeoplasmsCranial Nerve DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, OperativeMicromanipulationInvestigative TechniquesRadiotherapyTherapeuticsStereotaxic TechniquesNeurosurgical Procedures

Study Officials

  • Ashkan Monfared, MD

    George Washington University

    STUDY DIRECTOR
  • Robert K Jackler, MD

    Stanford University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 10, 2010

First Posted

May 25, 2010

Study Start

March 1, 2005

Primary Completion

May 8, 2022

Study Completion

May 8, 2022

Last Updated

May 10, 2022

Record last verified: 2022-05

Locations